The U.S. Department of State announced new visa restrictions on 13 individuals associated with KS International Traders and its owner, an India-based online pharmacy. This measure comes as part of a broader American crackdown on the illicit fentanyl trade, targeting entities responsible for distributing counterfeit prescription pills laced with the dangerous opioid to unsuspecting U.S. citizens.
Targeting Illicit Drug Networks
State Department spokesman Tommy Pigott confirmed the restrictions, stating that the individuals are linked to KS International Traders, which has been identified as a significant distributor of fentanyl-laced counterfeit medications. The U.S. government views fentanyl trafficking as a critical threat, with former President Donald Trump having designated the substance a Weapon of Mass Destruction.
This latest action, taken under Section 212(a)(3)(C) of the Immigration and Nationality Act, reinforces the commitment of both the United States and India to disrupt and dismantle drug trafficking operations. Pigott emphasized that those complicit in poisoning Americans will be denied entry into the United States.
Previous Sanctions and Ongoing Enforcement
The current visa restrictions build upon earlier enforcement actions. Last September, the U.S. Treasury's Office of Foreign Assets Control (OFAC) sanctioned two Indian nationals, Sadiq Abbas Habib Sayyed and Khizar Mohammad Iqbal Shaikh, along with KS International Traders, the online pharmacy Shaikh operated. These individuals were accused of collaborating with traffickers in the U.S. and the Dominican Republic to distribute counterfeit pills containing fentanyl, fentanyl analogues, and methamphetamine.
The pressure on India-linked fentanyl networks has intensified. Last month, OFAC sanctioned Satishkumar Hareshbhai Sutaria, a pharmaceutical chemicals supplier, for allegedly trading in fentanyl precursors destined for illicit production in Mexico and Guatemala. Sutaria reportedly worked with salesperson Yuktakumari Ashishkumar Modi, utilizing two India-based firms, SR Chemicals and Pharmaceuticals and Agrat Chemicals and Pharmaceuticals, to facilitate these transactions. Both Sutaria and Modi were arrested by Indian authorities in March 2025, underscoring the collaborative efforts between the two nations.
A Shared Commitment Against Trafficking
These persistent actions highlight the enduring partnership between the United States and India in combating transnational organized crime and illicit drug trafficking. By targeting key individuals and entities involved in the fentanyl supply chain, both nations aim to protect their citizens from the devastating impact of opioid abuse and disrupt the financial networks that fuel this deadly trade.